Effects of janus-kinase inhibitor therapy on lipid parameters in patients with IBD

被引：0
|
作者：
Prabhu, A. [1 ]
Al Dehailan, R. [1 ]
Azzu, H. [1 ]
Sanford, J. [1 ]
Cripps, S. [1 ]
Scaria, L. [1 ]
Walsh, A. [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Translat Gastroenterol Unit, Oxford, England
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
10.1093/ecco-jcc/jjae190.1335
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1161
引用
收藏
页码：i2123 / i2123
页数：1
相关论文
共 50 条
  • [21] Cardiovascular safety of Janus Kinase inhibitor therapy in a multi-ethnic population
    Sunmboye, Kehinde
    Petrie, Tom
    Durrani, Maumer
    MUSCULOSKELETAL CARE, 2024, 22 (01)
  • [22] Janus Kinase Inhibitor Therapy for Cicatricial Alopecias: An Evidence-Based Review
    Sood, Siddhartha
    Bagit, Ahmed
    Seeburruth, Darshana
    Sachdeva, Muskaan
    Maliyar, Khalad
    Abduelmula, Abrahim
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (05) : 505 - 506
  • [23] Herpes zoster subunit vaccine for patients initiating a Janus kinase inhibitor
    Waldman, Reid A.
    Bsn, Kelley L. Sharp
    Adalsteinsson, Jonas A.
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 697 - 698
  • [24] Janus Kinase Inhibitors Do Not Impact Male Sexual Health or Fertility Outcomes in IBD Patients
    Alsabbagh, Muaz
    El Telbany, Ahmed
    Alchirazi, Khaled Alsabbagh
    Qapaja, Thabet
    Albuni, Mhd Kutaiba
    Regueiro, Miguel D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1003 - S1003
  • [25] Reversible Effects on Female Fat Fertility with Abrocitinib: A Janus Kinase 1 Inhibitor
    Bowman, Christopher J.
    Campion, Sarah N.
    Catlin, Natasha R.
    Nowland, William S.
    Stethem, Christine M.
    Radi, Zaher A.
    Cappon, Gregg D.
    BIRTH DEFECTS RESEARCH, 2024, 116 : S48 - S48
  • [26] Reversible effects on female rat fertility with abrocitinib, a Janus kinase 1 inhibitor
    Bowman, Christopher J.
    Campion, Sarah N.
    Catlin, Natasha R.
    Nowland, William S.
    Stethem, Christine M.
    Radi, Zaher A.
    Cappon, Gregg D.
    BIRTH DEFECTS RESEARCH, 2024, 116 (05):
  • [27] Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy
    Lorena Castiblanco, Laura
    Garcia de Yebenes, Maria Jesus
    Martin Martin, Jose Maria
    Carmona, Loreto
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (12) : 2125 - 2133
  • [28] EFFECTS OF TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, ON PATIENT-REPORTED OUTCOMES IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS
    Yamanaka, H.
    Tanaka, Y.
    Takeuchi, T.
    Sugiyama, N.
    Hirose, T.
    Yoshii, N.
    Morishima, Y.
    Toyoizumi, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 274 - 275
  • [29] Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy
    Laura Lorena Castiblanco
    María Jesús García de Yébenes
    Jose María Martín Martín
    Loreto Carmona
    Rheumatology International, 2022, 42 : 2125 - 2133
  • [30] In the presence of a PFO, a paradoxical embolism triggered by hormone replacement therapy and Janus Kinase inhibitor
    Hamaad, A.
    Yusuf, M.
    Aslanian, A.
    Mohamed, S.
    Yaqub, S.
    Nguyen, D.
    Walker, J.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369
12345